Evidence map›Paper›PMID 40969819›Full record

ArticleJuntendo medical journal2025

Safety of Platelet-rich Plasma Treatment for Oral Diseases.

Morikuni Tobita, Anna Arita, Yosuke Masubuchi, Keiko Wakana, Hikari Yoneda, Shunsuke Namaki, Takaaki Tamagawa, Mitsuyo Shinohara

Abstract read
In one paragraph

Article in Juntendo medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Morikuni Tobita
Anna Arita
Yosuke Masubuchi
Keiko Wakana
Hikari Yoneda
Shunsuke Namaki
Takaaki Tamagawa
Mitsuyo Shinohara

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Platelet-rich plasma (PRP), obtained by centrifuging autologous blood, is widely used for pain relief and wound healing. PRP is also used in the dental field, but the safety and validity thereof for dental diseases have not yet been fully established. We aimed to evaluate the safety of PRP for the following dental procedures: post-extraction socket healing, maxillary sinus floor elevation, periodontal tissue regeneration, and intentional tooth replantation. Materials: PRP was purified from patient's own venous blood and transplanted. Methods: Eight patients were enrolled in clinical trials targeting four dental diseases, and subjected to the required treatment with transplantation (two patients/study). The primary endpoint was safety; specifically, adverse events after PRP treatment were evaluated based on clinical observations. Secondary endpoints were clinical evaluation, dental radiography and/or imaging evaluation, and platelet count. Results: No serious adverse events associated with the PRP transplantation were observed. In tooth extraction sockets, postoperative pain tended to subside the day after treatment. Regeneration of hard tissue at the PRP transplant site has been confirmed in clinical studies on maxillary sinus lifts, periodontal tissue regeneration, and tooth replantation. Conclusions: Our findings demonstrate the safety and validity of PRP transplantation for each type of dental disease. Because the sample size was limited, further large-scale clinical studies are required to evaluate the safety and validity of PRP treatment for each dental disease.

Indexed as

oral diseaseplatelet-rich plasmaregenerative medicinesafety

Identifiers

PMID40969819
PMCPMC12441177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.